On December 24, 2002, the U.S. Court of Appeals for the District of Columbia Circuit struck down a Maine law that imposes strict controls on the price of prescription drugs sold in the State. The decision was a victory for WLF, which filed a brief in the case. The Court agreed with WLF that the Maine price control scheme is void because it conflicts with federal laws regulating the sale of prescription drugs. The court further agreed that the U.S. Department of Health and Human Services acted improperly in approving the program.